Kettering, S.A.

Receive alerts:
by e-mail
E-mail Your information will be added to a database with the sole purpose of serving your subscription. This database is the exclusive property of vLex Networks S.L. and will never be shared with any other company. By sending your request you accept the Data Protection Policy of vLex Networks S.L. I have read and accept the Terms of Use
via RSS

76 documents for Kettering, S.A.

- State v. Brewer, (Ohio 2004)
... her a ride to her uncle's business in Kettering because she had a gift to drop off for her son who... right inner thigh revealed the presence of saliva which contained a mixture of DNA consistent with S...
- Ohio Supreme Court
- Hyde Park Senses Success ; Electronics Company Expects 18 Percent Boost in Sales
KETTERING -- Hyde Park Electronics, a local company whose sensors tell Pepsi and Budweiser packaging lines when a can is missing, is planning for a big 2005 with a sales growth target of 18 percent. The economic slowdown of the past three years skipped the small, family-owned electronics company that was acquired two years ago by Paris-based Schneider Electric SA.
- Dayton Daily News
- January 18, 2005
- Cytheris Initiates INSPIRE 3, a Phase II Clinical Trial of Recombinant Human Interleukin-7 (CYT107) in Chronically Infected HIV Patients.
Study Will Assess Safety and Biological Activity of Repeated Cycles of CYT1...
- Business Wire
- September 21, 2010

- Cytheris Announces Publication of IL-7 HIV Data in The Journal of Clinical Investigation.
...PARIS -- Cytheris SA, a clinical stage biopharmaceutical company focuse...
- Business Wire
- March 17, 2009
- Prep Basketball
Saturday's scores Girls

... 18, Carpenter 4, Pellillo 6, Rizzo 2, Kettering 2, Collins 2. SA - Douglas 23, Fletcher 17, Canada...
- Sunday Gazette-Mail
- January 17, 2005
- Cytheris Announces Publication of Preclinical Study in Journal of Immunology Showing Interleukin-7 PromotesT Cell Viability, Trafficking, and Functionality While Improving Survival in Sepsis.
...PARIS -- Cytheris SA, a clinical stage biopharmaceutical company focuse... (being conducted at the Memorial Sloan-Kettering Cancer Center in New York City). . About Cytheris ...
- Business Wire
- March 16, 2010
- ; One Is Opening Near Ud; Other Near the Convention Center.
Three Dayton natives are coming back to town to launch a new sushi concept near the University of Dayton, and a second, separate Asian restaurant that offers Thai dishes and sushi is scheduled to open today in a high-profile downtown Dayton location. FUSIAN, a casual sushi bar located in downtown Cincinnati, announced it would open a second location at 1200 Brown St. this fall to serve the UD area.

... Weprin, one of three cofounders of FUSIAN, said the three owners are all Dayton-area natives. Wepr... connection -- owned by Saveth Yun of Kettering, who previously managed Teak Thai Cuisine in Cinci...
- Dayton Daily News
- July 01, 2011
- Cytheris Announces Notice of Allowance for U.S. Patent Covering the Pharmaceutical Composition of Its Recombinant Human Interleukin-7 (CYT107).
PARIS -- Cytheris SA, a clinical stage biopharmaceutical company focuse..., conducted at the Memorial Sloan-Kettering Cancer Center in New York City. . About Cytheris -...
- Business Wire
- July 08, 2009
- Cytheris Initiates INSPIRE 2, a Phase II Clinical Trial of Recombinant Human Interleukin-7 (CYT107) in Chronically Infected HIV Patients Who Fail to Achieve Optimal Immune Reconstitution under HAART Therapy.
Study is Designed to Confirm the Safety Profile, Pharmacokinetics and Immunological Effect...
- Business Wire
- January 12, 2010
- Cytheris Closes [euro]12 Million ($15 Million) Series D Financing.
...PARIS -- Cytheris SA, a clinical stage biopharmaceutical company focuse... (being conducted at the Memorial Sloan-Kettering Cancer Center in New York City). . About Cytheris ...
- Business Wire
- June 07, 2010